Piperidolate
Chemical compound / From Wikipedia, the free encyclopedia
Piperidolate is a pharmaceutical drug used to treat the symptoms of gastrointestinal disorders including gastric and duodenal ulcers, gastritis, enteritis, gallstones, cholecystitis, and biliary dyskinesia.[1] It acts as an antimuscarinic agent.[2][3] It was first approved in 1954 and is no longer marketed in the United States.[1]
Quick Facts Clinical data, Trade names ...
Clinical data | |
---|---|
Trade names | Dactil |
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
DrugBank |
|
ChemSpider |
|
UNII | |
KEGG |
|
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.001.318 |
Chemical and physical data | |
Formula | C21H25NO2 |
Molar mass | 323.436 g·mol−1 |
3D model (JSmol) | |
| |
| |
NY (what is this?) (verify) |
Close
- "Piperidolate". Inxight Drugs. National Center for Advancing Translational Sciences.
- "Piperidolate". drugs.com.
- Vardanyan R (2017). Piperidine-Based Drug Discovery. Elsevier Science. p. 130. ISBN 978-0-12-813428-3.
This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it. |